Selected research
Market Structure
Global Parecoxib Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Parecoxib Sodium market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Parecoxib Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Parecoxib Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Parecoxib Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Parecoxib Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Parecoxib Sodium include Sailong Pharma, Chiarai Tianqing, Qilu Pharma, Kelun Pharma and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Parecoxib Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Parecoxib Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Parecoxib Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Parecoxib Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.
Parecoxib Sodium Segment by Company
Sailong Pharma
Chiarai Tianqing
Qilu Pharma
Kelun Pharma
Pfizer
Parecoxib Sodium Segment by Type
Original Drug
Generic Drug
Parecoxib Sodium Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Parecoxib Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parecoxib Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parecoxib Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parecoxib Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Parecoxib Sodium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parecoxib Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Parecoxib Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Parecoxib Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Sailong Pharma
- Chiarai Tianqing
- Qilu Pharma
- Kelun Pharma
- Pfizer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Parecoxib Sodium Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Parecoxib Sodium Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Parecoxib Sodium Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Parecoxib Sodium Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Parecoxib Sodium Market Dynamics
- 2.1 Parecoxib Sodium Industry Trends
- 2.2 Parecoxib Sodium Industry Drivers
- 2.3 Parecoxib Sodium Industry Opportunities and Challenges
- 2.4 Parecoxib Sodium Industry Restraints
3 Parecoxib Sodium Market by Manufacturers
- 3.1 Global Parecoxib Sodium Revenue by Manufacturers (2021-2026)
- 3.2 Global Parecoxib Sodium Sales by Manufacturers (2021-2026)
- 3.3 Global Parecoxib Sodium Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Parecoxib Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Parecoxib Sodium Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Parecoxib Sodium Manufacturers, Product Type & Application
- 3.7 Global Parecoxib Sodium Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Parecoxib Sodium Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Parecoxib Sodium Players Market Share by Revenue in 2025
- 3.8.3 2025 Parecoxib Sodium Tier 1, Tier 2, and Tier 3
4 Parecoxib Sodium Market by Type
- 4.1 Parecoxib Sodium Type Introduction
- 4.1.1 Original Drug
- 4.1.2 Generic Drug
- 4.2 Global Parecoxib Sodium Sales by Type
- 4.2.1 Global Parecoxib Sodium Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Parecoxib Sodium Sales by Type (2021-2032)
- 4.2.3 Global Parecoxib Sodium Sales Market Share by Type (2021-2032)
- 4.3 Global Parecoxib Sodium Revenue by Type
- 4.3.1 Global Parecoxib Sodium Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Parecoxib Sodium Revenue by Type (2021-2032)
- 4.3.3 Global Parecoxib Sodium Revenue Market Share by Type (2021-2032)
5 Parecoxib Sodium Market by Application
- 5.1 Parecoxib Sodium Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Parecoxib Sodium Sales by Application
- 5.2.1 Global Parecoxib Sodium Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Parecoxib Sodium Sales by Application (2021-2032)
- 5.2.3 Global Parecoxib Sodium Sales Market Share by Application (2021-2032)
- 5.3 Global Parecoxib Sodium Revenue by Application
- 5.3.1 Global Parecoxib Sodium Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Parecoxib Sodium Revenue by Application (2021-2032)
- 5.3.3 Global Parecoxib Sodium Revenue Market Share by Application (2021-2032)
6 Global Parecoxib Sodium Sales by Region
- 6.1 Global Parecoxib Sodium Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Parecoxib Sodium Sales by Region (2021-2032)
- 6.2.1 Global Parecoxib Sodium Sales by Region (2021-2026)
- 6.2.2 Global Parecoxib Sodium Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Parecoxib Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Parecoxib Sodium Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Parecoxib Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Parecoxib Sodium Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Parecoxib Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Parecoxib Sodium Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Parecoxib Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Parecoxib Sodium Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Parecoxib Sodium Revenue by Region
- 7.1 Global Parecoxib Sodium Revenue by Region
- 7.1.1 Global Parecoxib Sodium Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Parecoxib Sodium Revenue by Region (2021-2026)
- 7.1.3 Global Parecoxib Sodium Revenue by Region (2027-2032)
- 7.1.4 Global Parecoxib Sodium Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Parecoxib Sodium Revenue (2021-2032)
- 7.2.2 North America Parecoxib Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Parecoxib Sodium Revenue (2021-2032)
- 7.3.2 Europe Parecoxib Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Parecoxib Sodium Revenue (2021-2032)
- 7.4.2 Asia-Pacific Parecoxib Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Parecoxib Sodium Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Parecoxib Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sailong Pharma
- 8.1.1 Sailong Pharma Company Information
- 8.1.2 Sailong Pharma Business Overview
- 8.1.3 Sailong Pharma Parecoxib Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sailong Pharma Parecoxib Sodium Product Portfolio
- 8.1.5 Sailong Pharma Recent Developments
- 8.2 Chiarai Tianqing
- 8.2.1 Chiarai Tianqing Company Information
- 8.2.2 Chiarai Tianqing Business Overview
- 8.2.3 Chiarai Tianqing Parecoxib Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Chiarai Tianqing Parecoxib Sodium Product Portfolio
- 8.2.5 Chiarai Tianqing Recent Developments
- 8.3 Qilu Pharma
- 8.3.1 Qilu Pharma Company Information
- 8.3.2 Qilu Pharma Business Overview
- 8.3.3 Qilu Pharma Parecoxib Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Qilu Pharma Parecoxib Sodium Product Portfolio
- 8.3.5 Qilu Pharma Recent Developments
- 8.4 Kelun Pharma
- 8.4.1 Kelun Pharma Company Information
- 8.4.2 Kelun Pharma Business Overview
- 8.4.3 Kelun Pharma Parecoxib Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Kelun Pharma Parecoxib Sodium Product Portfolio
- 8.4.5 Kelun Pharma Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Parecoxib Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Parecoxib Sodium Product Portfolio
- 8.5.5 Pfizer Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Parecoxib Sodium Value Chain Analysis
- 9.1.1 Parecoxib Sodium Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Parecoxib Sodium Production Mode & Process
- 9.2 Parecoxib Sodium Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Parecoxib Sodium Distributors
- 9.2.3 Parecoxib Sodium Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst